NoWay
It's time to play the game
Altra grana per Sanofi...doppio ko..
11/08/2022 10:59 - RSF
BUZZ-GSK, Sanofi, Haleon slump on "Zantac" lawsuits worries
** GSK, Sanofi and Haleon down sharply for second day on market jitters over potential negative implications from lawsuits in the U.S. over Zantac ** Heartburn medicine Zantac was withdrawn in 2019, which was linked with a probable cancer-causing impurity[urn:newsml:newsroom:20191021:nNRAa0a5t8:0] ** Analysts see possible negative newsflow from upcoming trials as a headwind, although possible damage is unclear ** "Zantac has arrived," writes Deutsche Bank on GSK/Sanofi ** "We don't think the evidence points to this as another glyphosate, but it is very possible we may see a liability of some $bn magnitude," it adds ** Credit Suisse recalls: "More than 2,000 cases have been filed in the US and the first trial begins on 22 August 2022, followed by the process of the multidistrict litigation beginning in September 2022 and the state bellwether trials in January 2023" ** CS however sees Haleon's involvement in Zantac litigation as limited. It says Haleon, in which GSK and Pfizer have a stake, has made no provision over Zantac ** By 0836 GMT, GSK down 2.7% after 5.5% drop in previous session. Sanofi down 2.9%, Haleon down 7.9%
(Reporting by Danilo Masoni)
Ammappa che legnate...
